Price exclusivity by what it covers: sole distribution earns a little more, sole use by one buyer earns a multiple
What exclusivity is worth depends on what it covers. Where it means sole distribution through one platform, platforms pay suppliers about 1.25 to 2 times the non-exclusive rate (Pond5 40 against 30 percent; Alamy 50 against 40 percent at its top tier only; Envato 62.5 to 87.5 percent kept against 45 percent, until it dropped the premium in 2026): what a platform pays for exclusive supply, so a floor, not what a buyer pays for sole use. In the one disclosed pair with the same buyer and the same data, GSK paid 23andMe $50M for a fifth exclusive year (2022) and $20M for a one-year non-exclusive licence (2023), about 2.5 times, though the exclusive years also carried a joint drug discovery collaboration and the later licence added new data. RL-environment founders put sole use by one buyer at 4 to 5 times. Waiving exclusivity has a separable dollar price: Tempus, as licensee, gave up exclusivity on a data licence carried at over $40.1M gross in return for $7.9M lower future payments, and wrote the asset down by $7.4M. Troveo's worked example (100 units non-exclusive, 150 or sometimes 200 exclusive) is an illustration, not a deal.
Dated 10 Sep 2026Source checked 19 Oct 2026Basis: strong
“Announced that GSK, our key collaborator in therapeutics, elected to extend the exclusive target discovery period under the collaboration agreement for a fifth year to discover and validate novel drug targets using 23andMe’s proprietary genetic and health survey database. 23andMe will receive a one-time payment of $50 million”
23andMe, exhibit 99.1 to Form 8-K (GSK extends the exclusive period for a fifth year), checked 10 Feb 2022
23andMe, exhibit 99.1 to Form 8-K (one-year non-exclusive data licence to GSK), checked 30 Oct 2023
Tempus AI, annual report on Form 10-K for 2025 (SEC), checked 24 Feb 2026
Tempus AI, filing with the SEC, November 2023 (size of the licensed data asset), checked 13 Nov 2023
Envato: Introduction to earnings (archived June 2026, version of 24 January 2026), checked 24 Jan 2026
Envato: Introduction to earnings (archived September 2026, version of 7 September 2026), checked 7 Sep 2026
Pond5: Exclusive artist program (archived July 2025), checked 29 Jul 2025
Alamy: Contributor contract (in force from 1 September 2026), checked 1 Sep 2026
Epoch AI: The state of RL environments, checked 12 Jan 2026
Everything read from this source (17)Archived copy, 16 Oct 2026
Troveo: Exclusive vs non-exclusive data license (worked example, illustrative units, not a deal), checked 10 Sep 2026
- A fifth year of GSK's exclusive drug-target discovery period on 23andMe's genetic and health survey database (one further exclusive year, paid by GSK)
- Exclusivity and exclusivity windows
- A one-year non-exclusive licence to 23andMe's genetic and health survey database, including new data and some added analyses, to GSK (after the exclusive period ended)
- RL environment supply contract between a vendor and a smaller (neo) lab
- One especially complex software-engineering RL task with its grader (upper end reported to Epoch AI)
- Exclusive rights instead of shared rights
- 2.5 to 5 timesWhat an exclusive licence fetches, against a non-exclusive one
Cited in this guide